Signaling from the IL-2 receptor to the nucleus

Cytokine and Growth Factor Reviews

Volumn 8, Issue 4, 1997, Pages 313-332

  Lin, Jian Xin ^a   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

IL 2; IL 2 receptors; JAKs; Signal transduction; STATs

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN; PROTEIN SHC; PROTEIN TYROSINE KINASE; RECEPTOR SUBUNIT; SIGNAL-TRANSDUCING ADAPTOR MOLECULE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; CELL NUCLEUS; CHEMISTRY; COMBINED IMMUNODEFICIENCY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MOLECULAR CLONING; MOUSE; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PLEIOTROPY; RECEPTOR AFFINITY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031410650     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00021-X     Document Type: Short Survey

References (235)

1. 1. Smith, K. A., The interleukin 2 receptor. Annu Rev Cell Biol, 1989, 5, 397-425.
2. 2. Waldmann, T.A., The multi-subunit interleukin-2 receptor. Annu Rev Biochem, 1989, 58, 875-911.
3. 3. Morgan, D. A., Ruscetti, F. W. and Gallo, R., Selective in vitro growth of T lymphocytes from normal human hone marrow. Science, 1976, 193, 1007-1008.
4. 4. Abraham, R. T. and Wiederrecht, G. J., Immunopharmacology of rapamycin. Annu Rev Immunol, 1996, 14, 483-510.
5. 5. Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol, 1997, 15, 707-747.
6. 6. Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R. and Hamuro, J., Structure and expression of a cloned cDNA for human interleukin-2. Nature, 1983, 302, 305-310.
7. 7. Robb, R. J., Munck, A. and Smith, K. A., T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med, 1981, 154, 1455-1474.
8. 8. Uchiyama, T., Broder, S. and Waldmann, T. A., A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac ( + ) cells. J Immunol, 1981, 126, 1393-1397.
9. 9. Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A. and Greene, W. C., A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature, 1982, 300, 267-269.
10. 10. Leonard W. J., Depper, J. M., Crabtree, G. R., Rudikoff, S., Pumphrey, J., Robb, R. J., Kronke, M., Svetlik, P. B., Peffer, N. J., Waldmann, T. A. and Green, W. C., Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature, 1984, 311, 626-631.
11. 11. Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawani, K., Maeda, M., Uchiyama, T., Yodoi, J. and Honjo, T., Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature, 1984, 311, 631-635.
12. 12. Cosman, D., Cerretti, D. P., Larsen, A., Park, L., March, C., Dower, S., Gillis, S. and Urdal, D., Cloning, sequence and expression of human interleukin-2 receptor. Nature, 1984, 312, 768-771.
13. 13. Greene, W. C., Robb, R. J., Svetlik, P. B., Rusk, C. M., Depper, J. M. and Leonard, W. J., Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. J Exp Med, 1985, 162, 363-368.
14. 14. Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R. and Leonard, W. J., Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science. 1986, 234, 859-863.
15. 15. Tsudo, M., Kozak, R. W., Goldman. C. K. and Waldmann, T. A., Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA, 1986, 83, 9694-9698.
16. 16. Teshigawara, K., Wang, H. M., Kato, K. and Smith, K. A. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med. 1987, 165, 223-238.
17. 17. Bich-Thuy, L. T., Dukovich, M., Peffer, N. J., Fauci, A. S., Kehrl, J. H. and Greene, W. C., Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. J Immunol, 1987, 139, 1550-1556.
18. 18. Tsudo, M., Kitamura, F. and Miyasaka. M.. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc Natl Acad Sci USA, 1989, 86, 1982-1986.
19. 19. Hatakeyama, M., Tsudo, M., Minamoto, S., Kono, T., Doi, T., Miyata, T., Miyasaka, M. and Taniguchi, T.. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's Science. 1989, 244, 551-556.
20. 20. Arima, N., Kamio, M., Imada, K., Hori, T., Hattori, T., Tsudo, M., Okuma, M. and Uchiyama, T., Pseudo-high affinity interleukin 2 (IL-2) receptor tacks the third component that is essential for functional IL-2 binding and signaling. J Exp Med, 1992, 176, 1265-1272.
21. 21. Minamoto, S., Mori, H., Hatakeyama, M., Kono, T., Doi, T., Ide, T., Uede, T. and Taniguchi. T., Characterization of the heterodimeric complex of human IL-2 receptor α.β chains reconstituted in a mouse fibroblast cell line. L929, J Immunol, 1990, 145, 2177-2182.
22. 22. Tsudo, M., Karasuyama, H., Kitamura, F., Tanaka, T., Kubo, S., Yamamura, Y., Tamatani, T., Hatakeyama, M., Taniguchi, T. and Miyasaka, M., The IL-2 receptor β-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms. J Immunol, 1990, 145, 599-606.
23. 23. Takeshita, T., Asao, H., Suzuki, J. and Sugamura, K.. An associated molecule, p64, with high-affinity interleukin 2 receptor. Int Immunol, 1990, 2, 477-480.
24. 23a. Saito, Y., Tada, H.. Sabe, H. and Honjo, T. Biochemical evidence for a third chain of the interleukin-2 receptor. J Biol Chem, 1991, 266, 22186-22191.
25. 24. Sharon M., Siegel J. P., Tosato, G., Yodoi, J., Gerrard, T. L. and Leonard W. J., The human interleukin 2 receptor β chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med, 1988, 167, 1265-1270.
26. 25. Takeshita, T.. Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka. N., Munakata, H., Nakamura, M. and Sugamura, K., Cloning of the γ chain of the human IL-2 receptor. Science 1992, 257, 379-382.
27. 26. Cao, X., Kozak. C. A., Liu, Y. J., Noguchi, M.. O'Connell, E. and Leonard, W. J., Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) γ chain: chromosomal mapping and tissue specificity of IL-2R γ chain expression. Proc Natl Acad Sci USA, 1993, 90, 8464-8468.
28. 27. Wang, H. M. and Smith, K. A., The interleukin 2 receptor. Functional consequences of its bimolecular structure J Exp Med, 1987. 166, 1055-1069.
29. 28. Lowenthal, J. W. and Greene, W. C., Contrasting interleukin 2 binding properties of the α (p55) and β (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med, 1987, 166, 1156-1161.
30. 29. Siegel, J. P., Sharon, M., Smith, P. L. and Leonard, W. J., The IL-2 receptor β chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science, 1987. 238, 75-78.
31. 30. Dukovich, M., Wano, Y., Le thi Bich ThuyKatz, P., Cullen, B. R.. Kehrl J. H. and Green, W. C., A second human interleukin-2 binding protein that may be a component on high-affinity interleukin-2 receptors. Nature. 1987, 327, 518-522.
32. 31. Tsudo, M., Goldman, C. K., Bongiovanni, K. F., Chan, W. C., Winton, E. F., Yagita, M., Grimm, E. A. and Waldmann T. A., The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci USA, 1987, 84, 5394-5398.
33. 32. Leonard, W. J., Kronke, M., Peffer, N. J., Depper, J. M. and Greene, W. C., Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci USA, 1985. 82, 6281-6285.
34. 33. Asao. H., Takeshita, T., Ishii, N.. Kumaki, S., Nakamura, M. and Sugamura, K., Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc Natl Acad Sci USA, 1993, 90, 4127-4131.
35. 34. Robb, R. J.. Greene, W. C. and Rusk, C. M., Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med, 1984, 160, 1126-1146.
36. 35. Leonard, W. J., Donlon, T A., Lebo, R. V. and Greene. W. C., Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. Science. 1985, 228, 1547-1549.
37. 36. Leonard, W. J., Depper, J. M., Kanehisa, M., Kronke, M., Peffer, N. J., Svetlik, P. B., Sullivan, M. and Greene, W. C., Structure of the human interleukin-2 receptor gene. Science. 1985, 230, 633-639.
38. 37. Ishida, N., Kanamori, H., Noma, T., Nikaido, T., Sabe H., Suzuki, N., Shimizu, A. and Honjo, T., Molecular cloning and structure of the human interleukin 2 receptor gene. Nucleic Acids Res, 1985, 13, 7579-7589.
39. 38. Bohnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R. and Greene, W. C., The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-α gene and type 1 HIV. Cell, 1988-. 53, 827-836.
40. 39. Leung, K. and Nabel. G. J., HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature, 1988, 333, 776-778.
41. 40. Cross, S. L., Halden, N. F., Lenardo, M. J. and Leonard. W. J., Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science, 1989, 244, 466-469.
42. 41. Ruben, S.. Poteat, H., Tan, T. H., Kawakami, K., Roeder, R., Haseltine, W. and Rosen, C. A., Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science, 1988, 241, 89-92.
43. 42. Ballard, D. W., Bohnlein, E.. Hoffman, J. A., Bogerd, H. P., Dixon, E. P., Franza, B. R. and Greene, W. C., Activation of the interleukin-2 receptor α gene: regulatory role for DNA-protein interactions flanking the κB enhancer. New Biol, 1989, 1, 83-92.
44. 43. Toledano, M. B., Roman, D. G., Halden, N. F., Lin, B. B. and Leonard, W. J., The same target sequences are differentially important for activation of the interleukin 2 receptor α-chain gene in two distinct T-cell lines. Proc Natl Acad Sci USA, 1990, 87, 1830-1834.
45. 44. Roman, D. G., Toledano, M. B. and Leonard, W. J., Sp1 represses IL-2 receptor α chain gene expression. New Biol, 1990, 2, 642-647.
46. 44a. John, S., Reeves, R. B., Lin, J.-X., Child, R.. Leiden, J., Thompson, C. B. and Leonard. W. J., Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I/Y and NF-κB family proteins. Mol Cell Biol, 1995, 15, 1786-1796.
47. 45. John S.. Robbin, C. M. and Leonard. W. J., An IL-2 response element in the human IL-2 receptor α chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J, 1996, 15, 5627-5635.
48. 46. Lecine, P., Algarte, M., Rameil, P., Beadling, C., Bucher, P., Nabholz, M. and Imbert, J., Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor α gene. Mol Cell Biol, 1996, 16, 6829-6840.
49. 47. Sperisen. P., Wang, S. M., Soldaini. E., Pla M., Rusterholz, C., Bucher, P., Corthesy, P., Reichenbach P. and Nabholz, M., Mouse interleukin-2 receptor α gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J Biol Chem, 1995, 270, 10743-10753.
50. 47a. Nakajima. H., Liu, X-W., Wynshaw-Boris, A., Rosenthal, L. A., Imada, K., Finbloom, D. S., Hennighausen, L. and Leonard, W. J., An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity, 1997. 7, 691-701.
51. 48. Ascherman, D. P., Migone, T. S., Friedmann, M. C. and Leonard W. J., Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor α chain gene. Critical role of two functionally reductant tyrosine residues in the IL-2 receptor β chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. J Biol Chem 1997. 272, 8704-8709.
52. 49. Gnarra, J. R., Otani, H., Wang, M. G., McBride, O. W., Sharon, M. and Leonard, W. J., Human interleukin 2 receptor β-chain gene: chromosomal localization and identification of 5 regulatory sequences. Proc Natl Acad Sci USA, 1990, 87, 3440-3444.
53. 50. Shibuya, H., Yoneyama, M., Nakamura, Y., Hanida, H., Hatakeyama, M., Minamoto, S., Kono, T., Doi, T., White, R. and Taniguchi, T., The human interleukin-2 receptor β-chain gene: genomic organization, promoter analysis and chromosomal assignment. Nucleic Acids Res, 1990, 18, 3697-3703.
54. 51. Cerdan, C., Martin, Y., Courcoul, M., Mawas, C., Birg, F. and Olive, D., CD28 costimulation up-regulates long-term IL-2R β expression in human T cells through combined transcriptional and post-transcriptional regulation. J Immunol, 1995, 154, 1007-1013.
55. 52. Casey, L. S., Lichtman, A. H. and Boothby, M., IL-4 induces IL-2 receptor p75 β-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. J Immunol, 1992, 148, 3418-3426.
56. 53. Nakanishi, K., Hirose, S., Yoshimoto, T., Ishizashi, H., Hiroishi, K., Tanaka, T., Kono, T., Miyasaka, M., Taniguchi, T. and Higashino, K., Role and regulation of interleukin (IL)-2 receptor α and β chains in IL-2-driven B-cell growth. Proc Natl Acad Sci USA, 1992, 89, 3551-3555.
57. 54. Lin, J.-X., Bhat, N. K., John, S., Queale, W. S. and Leonard. W. J., Characterization of the human interleukin-2 receptor β-chain gene promoter: regulation of promoter activity by ets gene products. Mol Cell Biol, 1993, 13, 6201-6210.
58. 55. Lin, J.-X. and Leonard, W. J., The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor β-chain promoter through noncanonical Egr and Sp1 binding sites. Mol Cell Biol, 1997, 17, 3714-3722.
59. 56. Skerka, C., Decker, E. L. and Zipfel, P. F., A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J Biol Chem, 1995, 270, 22500-22506.
60. 57. Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W. and Leonard, W. J., Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell, 1993, 73, 147-157.
61. 58. Noguchi, M., Adelstein, S., Cao, X. and Leonard, W. J., Characterization of the human interleukin-2 receptor γ chain gene. J Biol Chem, 1993, 268, 13601-13608.
62. 59. Can, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsall, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A. and Bloom, E. T., Paul, W. E., Katz, S. I., Love, S. E. and Leonard, W. J., Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity, 1995, 2, 223-238.
63. 60. Bosco, M. C., Espinoza-Delgado, I., Schwabe, M., Russell, S. M., Leonard, W. J., Longo, D. L. and Varesio, L., The γ subunit of the interleukin-2 receptor is expressed in human monocytes and modulated by interleukin-2, interferon γ, and transforming growth factor β1. Blood, 1994, 83, 3462-3467.
64. 61. Ohbo, K., Takasawa, N., Ishii, N., Tanaka, N., Nakamura, M. and Sugamura, K., Functional analysis of the human interleukin 2 receptor γ chain gene promoter. J Biol Chem, 1995, 270, 7479-7486.
65. 62. Lenardo, M. J., Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature, 1991, 353, 858-861.
66. 63. Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C.. Cannella, B., Raine, C. S., Goverman, J. and Lenardo. M. J., T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis, Science, 1994, 263, 1139-1143.
67. 64. Mingair, M. C., Gerosa, F., Carra, G., Accolla, R. S., Moretta, A., Zubler, R. H., Waldmann, T. A. and Moretta, L., Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature, 1984, 312, 641-643.
68. 65. Tsudo, M., Uchiyama, T. and Uchino, H., Expression of Tac antigen on activated normal human B cells. J Exp Med, 1984, 160, 612-617.
69. 66. Zubler, R. H., Lowenthal, J. W., Erard, F., Hashimoto. N., Devos, R. and MacDonald, H. R., Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med, 1984, 160, 1170-1183.
70. 67. Nakanishi, K., Malek, T. R., Smith, K. A., Hamaoka, T., Shevach, E. M. and Paul, W. E., Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J Exp Med, 1984, 160, 1605-12621.
71. 68. Waldmann, T. A., Goldman, C. K., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., Bongiovanni, K. F., Korsmeyer. S. J. and Greene, W. C.. Expression of interleukin 2 receptors on activated human B cells. J Exp Med, 1984, 160, 1450-1466.
72. 69. Loughnan, M. S. and Nossal, G. J., Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains. Nature, 1989, 340, 76-79.
73. 70. Blackman, M. A., Tigges, M. A., Minie, M. E. and Koshland, M. E., A model system for peptide hormone action in differentiation: interleukin 2 induces a B lymphoma to transcribe the J chain gene. Cell. 1986, 47, 609-617.
74. 71. Lansford, R. D., McFadden, H. J., Siu, S. T., Cox, J. S., Cann, G. M. and Koshland, M. E., A promoter clement that exerts positive and negative control of the interleukin 2-responsive J-chain gene. Proc Natl Acad Sci USA, 1992, 89, 5966-5970.
75. 72. McFadden, H. J. and Koshland, M. E., Interleukin 2-and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter. Proc Natl Acad Sci USA, 1991, 88, 11027-11031.
76. 73. Rinkenberger, J. L., Wallin, J. J., Johnson, K. W. and Koshland, M. E., An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity, 1996, 5, 377-386.
77. 74. Domzig, W., Stadler, B. M. and Herberman, R. B., Interleukin 2 dependence of human natural killer (NK) cell activity. J Immunol, 1983, 130, 1970-1973.
78. 75. Ortaldo, J. R., Mason, A. T., Gerard, J. P., Henderson, L. E., Farrar, W., Hopkins, R. F. D., Herberman, R. B. and Rabin, H., Effects of natural and recombinant IL 2 on regulation of IFN γ production and natural killer activity: lack of involvement: of the Tac antigen for these immunoregulatory effects. J Immunol, 1984, 133, 779-783.
79. 76. Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L. and Perussia, B., Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med, 1984, 160, 1147-1169.
80. 77. Lanier, L. L., Benike, C. J., Phillips, J.-H. and Engleman, E. G., Recombinant interleukin 2 enhanced natural killer cell-mediated cytoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol. 1985, 134, 794-801.
81. 78. Grimm, E. A., Rayner, A. A. and Wilson, D. J., Human NK resistant tumor cell lysis is effected by IL-2 activated killer cells. Adv Exp Med Biol, 1985, 184, 161-175.
82. 79. Harel-Bellan, A., Bertoglio, J., Quillet, A., Marchiol, C., Wakasugi, H., Mishall Z. and Fradelizi, D. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. J Immunol, 1986, 136, 2463-2469.
83. 80. London, L., Perussia, B. and Trinchieri, G., Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol, 1986, 137, 3845-3854.
84. 81. Talmadge, J. E., Wiltrout, R. H., Counts, D. F., Herberman, R. B., McDonald, T. and Ortaldo, J. R., Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes. Cell Immunol, 1986, 102, 261-272.
85. 82. Espinoza-Delgado, I., Orlaldo, J. R., Winkler-Pickett, R., Sugamura, K., Varesio, L. and Longo, D. L., Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med, 1990, 171, 1821-1826.
86. 83. Epling-Burnette, P. K., Wei, S., Blanchard, D. K., Spranzi, E. and Djeu, J. Y., Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor β. Blood, 1993, 81, 3130-3137.
87. 84. Malkovskyl, M., Loveland, B., North, M., Asherson, G. L., Gao, L., Ward. P. and Fiers, W., Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature, 1987, 325, 262-265.
88. 85. Musso, T., Johnston, J. A., Linnekin. D., Varesio, L., Rowe, T. K., O'Shea, J. J. and McVicar, D. W., Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med, 1995. 181, 1425-1431.
89. 86. Saraya, K. A. and Balkwill, F. R., Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression. Br J Cancer, 1993, 67, 514-521.
90. 87. Djeu, J. Y., Liu, J. H., Wei, S., Rui. H., Pearson, C. A., Leonard, W. J. and Blanchard, D. K., Function associated with IL-2 receptor-β on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol, 1993, 150, 960-970.
91. 88. Minami. Y.. Oishi, I., Liu, Z. J., Nakagawa, S., Miyazaki, T. and Taniguchi, T., Signal transduction mediated by the reconstituted IL-2 receptor. Evidence fora cell type-specific function of IL-2 receptor β-chain. J Immunol, 1494, 152, 5680-5690.
92. 89. Nakamura, Y., Russell, S. M., Mess, S. A., Friedmann, M., Erdos, M., Francois, C., Jacques, Y., Adelstein, S. and Leonard, W. J., Heterodimerization of the IL-2 receptor β-and γ-chain cytoplasmic domains is required for signalling. Nature, 12994, 396, 330-333.
93. 90. Nelson, B. H., Lord, J. D. and Greenberg, P. D., Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature. 1994, 369, 333-336.
94. 91. Kawahara, A.. Minami. Y. and Taniguchi, T., Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling. Mol Cell Biol, 1994, 14, 5433-5440.
95. 92. de Vos A. M., Ultsch, M. and Kossiakoff, A. A., Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science, 1992, 255, 306-312.
96. 93. Myszka, D. G., Arulanantham, P. R., Sana, T., Wu, Z., Motion, T. A. and Ciardelli. T. L.. Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci, 1996, 5, 2468-2478.
97. 94. Fukunaga, R., Ishizaka-Ikeda, E., Pan, C. X., Seto, Y. and Nagata, S., Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J, 1991, 10, 2855-2865.
98. 95. Murakami, M., Narazaki, M.. Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T. and Kishimoto, T.. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA, 1991, 88, 11349-11353.
99. 96. Lin, J.-X., Migone, T. S., Tsang, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., et al., The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity, 1995, 2, 331-339.
100. 97. Lin, J.-X., Mietz, J., Modi, W. S., Johns, S. and Leonard, W. J., Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem, 1996, 271, 10738-10744.
101. 98. Friedmann, M. C., Migone, T. S., Russell, S. M. and Leonard, W. J., Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA, 1996, 93, 2077-2082.
102. 99. Goldsmith, M. A., Lai, S. Y., Xu, W., Amaral, M. C., Kuezek, L. S., Parent, L. J., Mills, G. B., Tarr, K. L., Longmore, G. D. and Greene, W. C., Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the β chain and non-tyrosine residues of the γ, chain. J Biol Chem. 1995, 270, 21729-21737.
103. 100. Page, T. H. and Dallman, M. J., Molecular cloning of cDNAs for the rat interleukin 2 receptor α and β chain genes: differentially regulated gene activity in response to mitogenic stimulation. Eur J Immunol, 1991, 21, 2133-2138.
104. 101. Bazan, J. F., Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA, 1990, 87, 6934-6938.
105. 102. Sprang, S. R. and Bazan, J. F., Cytokine structural taxonomy and mechanisms of receptor engagement. Curr Opin Struc Biol, 1993, 3, 815.
106. 103. Leonard, W. J., Type I Cytokines and Interferons and Their Receptors. In Fundamental Immunology, Paul, W. E. ed. 1998, in press.
107. 104. Ihle, J. N., The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol, 1995, 60, 1-35.
108. 105. Leonard, W. J., O'Shea, J. J., Jaks and STATs: Biological Implications. Ann Rev Immunol. 1998, in press.
109. 106. Saltzman, E. M., Thom, R. R. and Casnellie, J. E., Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. J Biol Chem, 1988, 263, 6956-6959.
110. 107. Sharon, M., Gnarra, J. R. and Leonard, W. J., The β-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells. J Immunol, 1989, 143, 2530-2533.
111. 108. Farrar, W. L. and Ferris, D. K., Two-dimensional analysis of interleukin 2-regulated tyrosine kinase activation mediated by the p70-75 β subunit of the interleukin 2 receptor. J Biol Chem, 1989, 264, 12562-12567.
112. 109. Augustine, J. A., Schlager, J. W. and Abraham, R. T., Differential effects of interleukin-2 and interleukin-4 on protein tyrosine phosphorylation in factor-dependent murine T cells. Biochim Biophys Acta, 1990, 1052, 313-322.
113. 110. Merida, I. and Gaulton, G. N., Protein tyrosine phosphorylation associated with activation of the interleukin 2 receptor. J Biol Chem, 1990. 265, 5690-5694.
114. 111. Kumaki, S., Asao, H., Takeshita, T., Kurahayashi, Y., Nakamura, M., Beckers, T., Engels, J. W. and Sugamura, K., Cell type-specific tyrosine phosphorylation of IL-2 receptor β chain in response to IL-2. FEBS Lett, 1992. 310, 22-26.
115. 112. Otani, H., Erdos, M. and Leonard. W. J., Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J Biol Chem, 1993, 268, 22733-22736.
116. 113. Bolen, J. B., Thompson, P. A., Eiseman, E. and Horak, I. D., Expression and interactions of the Src family of tyrosine protein kinases in T lyumphocytes. Adv Cancer Res, 1991, 57, 103-149.
117. 114. Pawson, T., Protein modules and signalling networks. Nature. 1995, 373, 573-580.
118. 115. Cohen, G. B., Ren, R. and Baltimore, D., Modular binding domains in signal transduction proteins. Cell, 1995, 80, 237-248.
119. 116. Ren, R., Mayer, B. J., Cicchetti, P. and Baltimore, D., Identification of a ten-amino acid proline-rich SH3 binding site. Science, 1993, 259, 1157-1161.
120. 117. Horak, I. D., Gress, R. E., Lucas, P. J., Horak, E. M., Waldmann, T. A. and Bolen, J. B., T-lymphocyte interlenkin 2-dependent tyrosine protein kinase signal transduction involves the activation of p561ck. Proc Natl Acad Sci USA, 1991, 88, 1996-2000.
121. 118. Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A.. Levin, S. D.. Perlmutter, R. M. and Taniguchi, T., Interaction of the IL-2 receptor with the six-family kinase p561ck: identification of noel intermolecular association. Science. 1991, 252, 1523-1528.
122. kh complex in human T-cell activation. Immunol Rev. 1989, 111, 225-266.
123. 120. Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E. and Bolen, J. B., Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p561ck. Nature, 1989, 338, 257-259.
124. 121. Barber, E. K., Dasgupta, J. D., Schlossman, S. F., Trevillyan, J. M. and Rudd, C. E., The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p561ck) that phosphorylates the CD3 complex. Proc Nature Acad Sci USA, 1989, 86, 3277-3281.
125. 122. Minami, Y., Kono, T., Yamada, K. Kobayashi, N., Kawahara, A., Perlmutter, R. M. and Taniguchi, T., Association of p561ck with IL-2 receptor β chain is critical for the IL-2-induced activation of p561ck. EMBO J, 1993, 12, 759-768.
126. 123. Karnitz, L., Sutor, S. L., Torigoe, T., Reed, J. C., Bell, M. P., McKean, D. J., Leibson, P. J. and Abraham, R. T., Effects of p561ck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol, 1992, 12, 4521-4530.
127. 124. Shibuya, H., Yoneyama, M.. Ninomiya-Tsuji. J., Matsumoto, K. and Taniguchi, T., IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell, 1992, 70, 57-67.
128. 125. Otani, H., Siegel, J. P., Erdos, M., Gnarra, J. R., Toledano. M. B., Sharon. M., Mostowski, H., Feinberg, M. B., Pierce, J. H. and Leonard, W. J., Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor β chain: involvement of tyrosine kinase(s) other than p561ck. Proc Natl Acad Sci USA, 1992, 89, 2789-2793.
129. 126. Torigoe, T., Saragovi, H. U. and Reed, J. C., Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line. Proc Natl Acad Sci USA, 1992, 89, 2674-2678.
130. 127. Kobayashi, N., Kono, T., Hatakeyama, M., Minami, Y., Miyazaki, T., Perlmutter, R. M. and Taniguchi, T., Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction. Proc Natl Acad Sci USA, 1993, 90, 4201-4205.
131. 128. Minami, Y.. Nakagawa, Y., Kawahara, A., Miyazaki, T., Sada, K., Yamamura, H. and Taniguchi, T., Protein tyrosine kinase Syk is associated with the activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity. 1995, 2, 89-100.
132. 129. Chan, A. C, Irving, B. A. and Weiss, A., New insights into T-cell antigen receptor structure and signal transduction. Curr Opin Immunol, 1992, 4, 246-251.
133. 130. Wange, R. J., Kong, A. N. and Samelson, L. E., A tyrosine-phosphorylated 70-kDa protein binds a photoaffinity analogue of ATP and associates with both the ζ chain and CD3 components of the activated T cell antigen receptor. J Biol Chem, 1992, 267, 11685-11688.
134. 131. Straus, D. B. and Weiss, A., The CD3 chains of the T cell antigen receptor associate with the ZAP-70 tyrosine kinase and are tyrosine phosphorylated after receptor stimulation. J Exp Med, 1993, 178, 1523-1530.
135. 132. Law, C. L., Sidorenko, S. P., Chandran, K. A., Draves, K. E., Chan, A. C., Weiss, A., Edelhoff, S., Disteche, C. M. and Ciark, E. A., Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J Biol Chem, 1994, 269, 12310-12319.
136. 133. Takeshita, T., Arita, T., Higuchi, M., Asao, H., Endo, K., Kuroda, H., Tanaka, N., Murata, K.. Ishii, N. and Sugamura, K., STAM, signal transuding adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity, 1997, 6, 449-457.
137. 134. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Fulong, M. T., Geahlen, R. L. and Tybulewicz, V. L., Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995, 378, 298-302.
138. 135. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B. and Pawson, T., Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 1995, 378, 303-306.
139. 136. Cambier, J. C., Pleiman, C. M. and Clark, M. R., Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol, 1994. 12, 457-486.
140. 137. Burns, L. A., Karnitz, L. M., Sutor, S. L. and Abraham. R. T., Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J Biol Chem, 1993, 268, 17659-17661.
141. 138. Cutler, R. L., Liu, L., Damen, J. E. and Krystal. G., Multiple cytokines induce the tyrosine phosphorylation of She and its association with Grb2 in hemopoietic cells. J Biol Chem, 1993, 268, 21463-21465.
142. 139. Ravichandran, K. S., Burakoff, S. J., The adapter protein She interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem, 1994, 269, 1599-1602.
143. 140. Liu, L., Damen, J. E., Cutler. R. L. and Krystal, G., Multiple cytokines stimulate the binding of a common 145-kilodalton protein to She at the Grb2 recognition site of She, Mol Cell Biol, 1994, 14, 6926-6935.
144. 141. Zhu, X., Suen, K. L., Barbacid, M., Bolen, J. B. and Fargnoli, J., Interleukin-2-induced tyrosine phosphorylation of She proteins correlates with factor-dependent T cell proliferation. J Biol Chem, 1994, 269, 5518-5522.
145. 142. Satoh, T., Nakafuku, M., Miyajima, A. and Kaziro, Y., Involvement of ras p21 protein in signal-transduetion pathways from interleukin 2, tnterleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA, 1991, 88, 3314-3318.
146. 143. Duronio, V., Welham, M. J., Abraham, S., Dryden, P. and Schrader, J. W. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21 ras GTPase-activating protein. Proc Natl Acad Sci USA, 1992, 89, 1587-1591.
147. 144. Welham, M. J., Dechert. U., Leslie, K. B. Jirik, F. and Schrader, J. W., Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4 induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase. J Biol Chem, 1994, 269, 23764-23768.
148. 145. Welham, M. J., Duronio, V., Leslie, K. B., Bowtell. D. and Scehrader, J. W., Multiple hemopoietins, with the exception of interleukin-4, induce modification of She and mSosl, but not their translocation. J Biol Chem, 1994, 269, 21165-21176.
149. 146. Turner, B., Rapp, U., App, U., Greene, M., Dobashi, K. and Reed, J., Interleukin 2 induces tyrosine phosphoryltition and activation of p72-74 Raf-1 kinase in a T-cell line. Proc Natl Acad Sci USA, 1991, 88, 1227-1231.
150. 147. Karnitz, L. M., Burns, L. A., Sutor, S. L., Blenis, J. and Abraham, R. T., Interleukin-2 triggers a novel phosphatidylinositol 3-dinase-dependent MEK activation pathway. Mol Cell Biol, 1995, 15, 3049-3057.
151. 148. Perkins, G. R., Marvel, J. and Collins, M. K., Interleukin 2 activates extracellular signal-regulated protein kinase 2. J Exp Med, 1993, 178, 1429-1434.
152. 149. Ravichandran, K. S., Igras, V., Shoelson, S. E., Fesik, S. W. and Burakoff, S. J., Evidence for a role for the phosphotyrosine-binding domain of She in interleukin 2 signaling. Proc Natl Acad Sci USA, 1996, 93, 5375-5280.
153. 150. Taniguchi, T., Cytokine signaling through nonreceptor protein tyrosine kinases. Science, 1995, 268, 251-255.
154. 151. Carpenter, C. L. and Cantley, L. C. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim Biophys Acta, 1996, 1288, M11-6.
155. 152. Zvelebil, M. J., MacDougall, L., Leevers, S., Volinia S., Vanhaesebroeck, B., Gout, I., Panayotou, G., Domin, J., Stein, R., Pages, F., et al., Structural and functional diversity of phosphoinositde 3-kinases. Philos Trans R Soc Land B Biol Sci, 1996, 351, 217-223.
156. 153. Augustine, J. A., Sutor, S. L. and Abraham, R. T., interleukin 2-and polymavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol Cell Biol, 1991, 11, 4431-4440.
157. 154. Merida, I.. Diez, E. and Gaulton, G. N., IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. J Immunol, 1991, 147, 2202-2207.
158. 155. Rumillard, B., Petrillo, R., Maslinski, W.. Tsudo, M., Strom, T. B., Cantley. L. and Varticovski, L., Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J Biol Chem, 1991, 266, 14167-14170.
159. 156. Merida, I., Williamson, P., Kuziel, W. A., Greene, W. C. and Gaulton, G. N., The serine-rich cytoplasmic domain of the interleukin-2 receptor β chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J Biol Chem, 1993, 268, 6765-6770.
160. 157. Calvo, V., Crews. C. M., Vik, T. A. and Bierer, B. E., Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci USA, 1992, 89, 7571-7575.
161. 158. Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J. and Crabtree, G. R., Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992, 358, 70-73.
162. 159. Sawami, H., Terada, N., Franklin, R. A., Okawa, H., Uhiyama, T., Lucan, J. J., Gelfand, E. W., Signal transduction by interleukin 2 in human T cells: activation of tyrosine and ribosomal S6 kinases and cell-cycle regulatory genes. J Cell Physiol, 1992, 151, 367-377.
163. 160. Monfar, M., Lemon, K. P., Grammer. T. C., Cheatham, L., Chung, J., Vlahos, C. J. and Blenis, J., Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol. 1995. 15, 326-337.
164. 161. Reif, K., Burgering, B. M. and Cantrell, D. A., Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J Biol Chem. 1997, 272, 14426-14433.
165. 162. Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O. and Tsichlis, P. N., Transduction of interleukin-2 anti-apoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA, 1997, 94, 3627-3632.
166. 163. Franke, T. F., Kaplan, D. R. and Cantley. L. C., P13K: downstream AKTion blocks apoptosis. Cell, 1997, 88, 435-437.
167. 164. Truitt, K. E., Mills, G. B., Turck, C. W. and Imboden, J. B., SH2-dependent association of phosphatidylinositol 3′-kinase 85-kDa regulatory subunit with the interleukin-2 receptor β chain. J Biol Chem. 1994, 269, 5937-5943.
168. 165. Karnitz, L. M., Sutor, S. L. and Abraham. R. T., The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J Exp Med, 1994, 179, 1799-1808.
169. 166. Taichman, R., Merida, I., Torigoe, T., Gaulton, G. N. and Reed, J. C., Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3′-kinase in interleukin-2-dependent T-cells. J Biol Chem, 1993, 268, 20031-20036.
170. 167. Bach, E. A., Aguet, M. and Schreiber, R. D., The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol, 1997, 15, 563-591.
171. 168. Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y. Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W. and O'Shea. J. J., Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature, 1994, 370, 151-153.
172. 169. Witthuhn, B. A., Silvennoinen, O., Miura, O.. Lai, K. S., Cwik, C., Liu, E. T. and Ihle, J. N.. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature, 1994, 370, 153-157.
173. c chains with Jak1 and Jalk3: implications for XSCID and XCID. Science. 1994, 266, 1042-1045.
174. 171. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z. J., Oishi. I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N. and Taniguchi, T., Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science. 1994, 266, 1045-1047.
175. c chain of the IL-2 receptor. Science. 1994, 266, 1039-1042.
176. 173. Russell, S. M., Tayebi, N., Nakajima. H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T. S.. Noguchi, M., Market, M. L., Buckley, R. H., O'Shea, J. J. and Leonard. W. J., Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 1995, 270, 797-800.
177. 174. Macchi, P., Villa, A., Gillani, S., Sacco, M. G.. Frattini, A., Porta, F., Ugazio, A. G.. Johnston, J. A., Candotti, F., O'Shea, J. J., Vezzoni. P. and Notarangelo. L. D.. Mutations of Jak3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 1995, 377, 65-68.
178. 175. Horvath, C. M. and Darnell, J. E.. The state of the STATs: recent developments in the sludy of signal transduction to the nucleus. Curr Opin Cell Biol, 1997, 9, 233-239.
179. 176. Nielsen. M., Svejgaard, A., Skov, S. and Odum, N., Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lyphocytes. Eur J Immunol, 1994, 24, 3082-3086.
180. 177. Hou, J., Schindler, Y., Henzel, W. J., Wong. S. C. and McKnight, S. L., Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity, 1995. 2, 321-329.
181. 178. Fujii, H., Nakagawa, Y., Schindler, U., Kawahara, A., Mori. H., Gouilleux, F., Groner, B., Ihle, J. N., Minami. Y., Miyazaki, T. and Taniguchi, T., Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA, 1995, 92, 5482-5486.
182. 179. Migone, T. S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J.. Franchini, G. and Leonard, W. J., Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science, 1995, 269, 79-81.
183. 180. Takeshita, S., Gage, J. R.. Kishmoto, T., Vredevoe, D. L., Martinez-Mazo, O., Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol, 1996, 156, 2591-2598.
184. 181. Danial, N. N., Pernis, A. and Rothman, P. B., Jak-STAT signaling induced by the v-abl oncogene. Science, 1995, 269, 1875-1877.
185. 182. Ohashi, T., Masuda, M. and Ruscetti, S. K., Activation of stat-related DNA-binding factors by erythropoietin and the spleen focus-forming virus. Curr Top Microbiol Immunol. 1996, 211, 223-231.
186. 183. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J. and Jove, R., Enhanced DNA-binding activity of a Stat3-relatcd protein in cells transformed by the Src oncoprotein. Science, 1995, 269, 81-83.
187. 184. Reed, J. C., Sabath, D. E., Hoover, R. G. and Prystowsky, M. B., Recombinant interleukin 2 regulates levels of c-myc mRNA in a choned murine T lymphocyte. Mol Cell Biol, 1985, 5, 3361-3368.
188. 185. Pauza, C. D., Regulation of human T-lymphocyte gene expression by interleukin 2: immediate-response genes include the proto-oncogene c-myb. Mol Cell Biol, 1987, 7, 342-348.
189. 186. Miyazaki, T., Liu, Z. J., Kawahara, A., Minami, Y.. Yamada, K., Tsujimoto, Y., Barsoumian. E. L., Permutter, R. M. and Taniguchi, T., Three distinct IL-2 signaling pathways mediated by bcl-2. c-myc, and lck cooperate in hematopoietic cell proliferation. Cell, 1995, 81, 223-231.
190. 187. Broome, H. E.. Dargan, C. M.. Krajewski, S. and Reed. J. C., Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol. 1995, 155, 2311-2317.
191. 188. Hatakeyatna, M., Kawahara, A., Mori, H.. Shibuya, H. and Taniguchi, T., c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor β chain. Proc Natl Acad Sci USA. 1992, 89, 2022-2026.
192. 189. Shibuya. H., Kohu, K., Yamada, K., Barsoumian, E. L., Perlmutter. R. M. and Taniguchi, T., Functional dissection of p561ck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene. Mol Cell Biol, 1994, 14, 5812-5819.
193. 190. Kawahara, A., Minami, Y., Miyazaki. T., Ihle, J. N. and Taniguchi, T., Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not hcl-2, gene induction. Proc Natl Acad Sci USA, 1995. 92, 8724-8728.
194. 191. Nelson, B. H., McIntosh, B. C., Rosencrans, L. L. and Greenberg, P. D., Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor γ(c) chain for Janus kinase activation leading to T cell proliferation. Proc Natl Acad Sci USA, 1997, 94, 1878-1883.
195. 192. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara. T. and Miyajima, A., A novel cytoktne-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J, 1995. 14, 2816-2826.
196. 193. Starr, R., Wilson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A. and Hilton, D. J.. A family of cytokine-inducible inhibitors of signalling. Nature, 1997. 387, 917-921.
197. 194. Endo, T. A., Masuhara. M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura. S., Ohtsubo, M., Misawa. H., Miyazaki. T.. Leonor, N.. Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. and Yoshimura, A., A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997, 387, 921-924.
198. 195. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S. and Kishimoto. T., Structure and function of a new STAT-induced STAT inhibitor. Nature. 1997, 387, 924-929.
199. 196. Yoshimura, A., Ichihara, M., Kinjyo, I., Moriyama, M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hara. T. and Miyajima, A., Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996, 15, 1055-1063.
200. 197. Brown, T. J., Rowe, J. M., Liu, J. W. and Shoyab, M., Regulation of IL-6 expression by oncostatin M. J Immunol, 1991, 147, 2175-2180.
201. 198. Malik, N., Haugen, H. S., Modrell, B., Shoyab, M. and Clegg, C. H., Development abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol. 1995. 15, 2349-2358.
202. c) by calpain. Proc Natl Acad Sci USA, 1997, 94, 11534-11539.
203. 200. Martin, S. J. and Green, D. R.. Protease activation during apoptosis: death by a thousand cuts? Cell. 1995. 82, 349-352.
204. 201. Kurman, C. C., Rubin, L. A. and Nelson, D. L.. Soluble products of immune activation: soluble iteleukin-2 receptor (sII-2R, Tac protein). In Manual of Clinical Laboratory Immunology. Rose, N. R., deMacario, E. C., Fahey, J. L., Friedman. H. Penn. G. M. eds, American Society for Microbiology. Washington, D.C.. 1992, 256-260.
205. 202. Fernandez-Botran, R., Chilton. P. M. and Ma, Y., Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv Immunol. 1996, 63, 269-336.
206. 203. Schorle. H.. Holtschke. T.. Hunig, T., Schimpl. A. and Horak, I., Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature, 1991, 352, 621-624.
207. 204. Kundig, T. M., Schorle, H., Bachmann, M. F.. Hengartner, H.. Zinkernagel R. M. and Horak. I., Immune responses in interleukin-2-deficient mice. Science, 1993, 262, 1059-1061.
208. 205. Sadlack, B., Merz. H., Schorle, H., Shimpl, A., Feller, A. C. and Horak, I., Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993, 75, 253-261.
209. 206. Willerford, D. M., Chen. J., Ferry. J. A., Davidson, L., Ma, A. and Alt, F. W., Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity, 1995, 3, 521-530.
210. 207. Sharfe, N., Dadi, H. K., Shahar, M. and Roifman, C. M., Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci USA, 1997. 94, 3168-3171.
211. 208. Grutiot-Deans, J., Merino, R., Nunez, G. and Turka, L. A.. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc Natl Acad Sci USA, 1994, 91, 10685-10689.
212. 209. Vanhecke, D.. Leclercq, G., Plum, J. and Vanderkerckhove, B., Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J Immunol, 1995, 155, 1862-1872.
213. 210. Burton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurrys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A., A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line. stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA, 1994, 91, 4935-4939.
214. 211. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A., The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T. that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA. 1994, 91, 4940-4944.
215. 212. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, Y., Beers, C.. Richardson, J., Schoenborn. M. A., Ahdieh. M., et al., Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science, 1994, 264, 965-968.
216. 213. Tagaya, Y., Bamford, R. N., Defilippis. A. P. and Waldmann, T. A., IL-15: a pleiotropic cytokine and diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 1996, 4, 329-336.
217. 214. Suzuki, H, Kundig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard. J. J., Ohashi, P. S., Griesser, H., Taniguchi, T., Paige, C. J. and Mak, T. W. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science. 1995, 268, 1472-1476.
218. 215. de Saint Basile G., Arveiler, B., Oberle, I., Malcolm, S., Levinsky, R. J., Lau, Y. L., Hofker, M., Debre, M., Fischer, A., Grisceli, C., et al., Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13. Proc Natl Acad Sci USA, 1987, 84, 7576-7579.
219. 216. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. W. and Leonard, W. J., Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science. 1993, 262, 1880-1883.
220. 217. Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X. and Leonard, W. J., Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science, 1993. 262, 1877-1880.
221. 218. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K. and Sugamura, K., Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science, 1993, 262, 1874-1877.
222. 219. Kondo, M., Takeshita, T.. Higuchi, M., Nakamura, M., Sudo, T., Nishikawa, S. and Sugamura, K., Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science, 1994, 263, 1453-1454.
223. 220. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S.. Cosman, D. and Anderson, D., Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J, 1994, 13, 2822-2830.
224. 221. Kimura. Y.. Takeshita, T., Kondo, M., Ishi, N., Nakamura, M., Van Snick, J. and Sugamura, K., Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex. Int Immunol, 1995, 7, 115-120.
225. c by the IL-2, IL-4 and IL-7 receptors: implications for X-linked severe combined immunodeficiency, (XSCID). Adv Exp Med Biol, 1994, 365, 225-232.
226. 221 DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A. and Rajewsky, K., Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA, 1995, 92, 377-381.
227. 224. Nakajima, H., Shores, E. W., Noguchi, M. and Leonard, W. J., The common cytokine receptor, γ chain plays an essential role in regulating lymphoid homeostasis. J Exp Med. 1997, 185, 189-195.
228. 225. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Gradbstein, K. and Caligiuri, M. A., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994, 180, 1395-1403.
229. c transduced severe combined immunodeficiency X1 hone marrow cells. Blood, 1996, 88, 3901-3909.
230. 227. Leclercq, G., Debacker, V., de Smedt, M. and Plum, J., Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med, 1996, 184, 325-336.
231. 228. Puzanov, I. J., Bennett, M. and Kumar, V., IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol, 1996, 157, 4282-4285.
232. 229. Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H. and Berg, L. J., Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science, 1995, 270, 794-797.
233. 230. Nosaka, T., van Deursen, J. M., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A. P., Doherty, P. C., Grosveld, G. C. and Ihle, J. N., Defective lymphoid development in mice lacking Jak3 [published erratum appears in Science, 1996, Jan 5; 271(5245): 17]. Science, 1995, 270, 800-802.
234. 231. Park, S. Y., Saijo, K., Takahashi, T., Osawa, M., Arase. H.. Hirayama, N.. Miyake, K., Nakauchi, H., Shirasawa, T. and Saito, T.. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity, 1995, 3, 771-782.
235. 232. Ohbo, K., Suda, T., Hashiyama, M., Mantani, A., Ikebe, M., Miyakawa, K., Moriyama, M., Nakamura, M.. Katsuki, M., Takahashi, K., Yamamura, K. and Sugamura, K., Modulation of haematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. Blood, 1996, 87, 956-967.